Data as of Apr 17
| -0.16 / -0.37%|
The 11 analysts offering 12-month price forecasts for Hospira Inc have a median target of 42.00, with a high estimate of 53.00 and a low estimate of 33.00. The median estimate represents a -1.96% decrease from the last price of 42.84.
The current consensus among 15 polled investment analysts is to Hold stock in Hospira Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.